{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:20:25Z","timestamp":1787876425652,"version":"build-2784847793"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2023R1A2C2005946"],"award-info":[{"award-number":["NRF-2023R1A2C2005946"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Future Medicine 2030 Project of the Samsung Medical Center","award":["#SMX1230771"],"award-info":[{"award-number":["#SMX1230771"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57137-6","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T16:46:20Z","timestamp":1781369180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ischemic injury and liver graft congestion increase post-transplant interleukin-6 and tumor necrosis factor-alpha in hepatocellular carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Young Ju","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyu-Seong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongman","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsoo","family":"Rhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"57137_CR1","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1038\/s41598-018-27319-y","volume":"8","author":"M Gr\u0105t","year":"2018","unstructured":"Gr\u0105t, M. et al. Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation. Sci. Rep. 8, 8935. https:\/\/doi.org\/10.1038\/s41598-018-27319-y (2018).","journal-title":"Sci. Rep."},{"key":"57137_CR2","doi-asserted-by":"publisher","unstructured":"Yamashita, S. et al. Remnant liver ischemia as a prognostic factor for cancer-specific survival after resection of colorectal liver metastases. JAMA Surg. 152, e172986. https:\/\/doi.org\/10.1001\/jamasurg.2017.2986 (2017).","DOI":"10.1001\/jamasurg.2017.2986"},{"key":"57137_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1001\/jamasurg.2016.5040","volume":"152","author":"JY Cho","year":"2017","unstructured":"Cho, J. Y. et al. Association of Remnant Liver Ischemia With Early Recurrence and Poor Survival After Liver Resection in Patients With Hepatocellular Carcinoma. JAMA Surg. 152, 386\u2013392. https:\/\/doi.org\/10.1001\/jamasurg.2016.5040 (2017).","journal-title":"JAMA Surg."},{"key":"57137_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/lt.23877","volume":"20","author":"SW Suh","year":"2014","unstructured":"Suh, S. W. et al. Hepatic venous congestion in living donor grafts in liver transplantation: is there an effect on hepatocellular carcinoma recurrence? Liver Transpl. 20, 784\u2013790. https:\/\/doi.org\/10.1002\/lt.23877 (2014).","journal-title":"Liver Transpl."},{"key":"57137_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/tri.13792","volume":"34","author":"J Rhu","year":"2021","unstructured":"Rhu, J., Kim, J. M., Jeong, W. K., Choi, G. S. & Joh, J. W. Venous outflow congestion is related to poor recurrence-free survival of living donor liver transplantation recipients with hepatocellular carcinoma - a retrospective study. Transpl. Int. 34, 272\u2013280. https:\/\/doi.org\/10.1111\/tri.13792 (2021).","journal-title":"Transpl. Int."},{"key":"57137_CR6","doi-asserted-by":"publisher","first-page":"e0195262","DOI":"10.1371\/journal.pone.0195262","volume":"13","author":"MS Chae","year":"2018","unstructured":"Chae, M. S. et al. Serum interleukin-6 and tumor necrosis factor-\u03b1 are associated with early graft regeneration after living donor liver transplantation. PLoS One. 13, e0195262. https:\/\/doi.org\/10.1371\/journal.pone.0195262 (2018).","journal-title":"PLoS One"},{"key":"57137_CR7","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1007\/s11033-010-0572-6","volume":"38","author":"MH Karimi","year":"2011","unstructured":"Karimi, M. H. et al. Association of IL-6 promoter and IFN-\u03b3 gene polymorphisms with acute rejection of liver transplantation. Mol. Biol. Rep. 38, 4437\u20134443. https:\/\/doi.org\/10.1007\/s11033-010-0572-6 (2011).","journal-title":"Mol. Biol. Rep."},{"key":"57137_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/07853890.2016.1257862","volume":"49","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Jin, W. & Cai, X. Anti-interleukin-2 receptor antibodies for the prevention of rejection in liver transplant recipients: a systematic review and meta-analysis. Ann. Med. 49, 365\u2013376. https:\/\/doi.org\/10.1080\/07853890.2016.1257862 (2017).","journal-title":"Ann. Med."},{"key":"57137_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cytogfr.2018.01.002","volume":"39","author":"S Naseem","year":"2018","unstructured":"Naseem, S., Hussain, T. & Manzoor, S. Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies. Cytokine Growth Factor. Rev. 39, 36\u201345. https:\/\/doi.org\/10.1016\/j.cytogfr.2018.01.002 (2018).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"57137_CR10","first-page":"119","volume":"13","author":"M Shuh","year":"2013","unstructured":"Shuh, M., Bohorquez, H., Loss, G. E. Jr. & Cohen, A. J. Tumor Necrosis Factor-\u03b1: Life and Death of Hepatocytes During Liver Ischemia\/Reperfusion Injury. Ochsner J. 13, 119\u2013130 (2013).","journal-title":"Ochsner J."},{"key":"57137_CR11","doi-asserted-by":"publisher","unstructured":"Fathi, F., Sanei, B., Ganjalikhani Hakemi, M., Saidi, R. F. & Rezaei, A. Liver resection promotes (regulates) proinflammatory cytokines in patients with hepatocellular carcinoma. Can. J. Gastroenterol. Hepatol. 2021 5593655. https:\/\/doi.org\/10.1155\/2021\/5593655 (2021).","DOI":"10.1155\/2021\/5593655"},{"key":"57137_CR12","doi-asserted-by":"publisher","first-page":"13739","DOI":"10.1038\/s41598-021-92888-4","volume":"11","author":"A Murtha-Lemekhova","year":"2021","unstructured":"Murtha-Lemekhova, A. et al. Influence of cytokines, circulating markers and growth factors on liver regeneration and post-hepatectomy liver failure: a systematic review and meta-analysis. Sci. Rep. 11, 13739. https:\/\/doi.org\/10.1038\/s41598-021-92888-4 (2021).","journal-title":"Sci. Rep."},{"key":"57137_CR13","first-page":"15","volume":"13","author":"M Pach\u00f3wka","year":"2008","unstructured":"Pach\u00f3wka, M., Zegarska, J., Ciecierski, R. & Korczak-Kowalska, G. The role of IL-6 during the late phase of liver regeneration. Ann. Transpl. 13, 15\u201319 (2008).","journal-title":"Ann. Transpl."},{"key":"57137_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1053\/jhep.2003.50378","volume":"38","author":"A Blindenbacher","year":"2003","unstructured":"Blindenbacher, A. et al. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 38, 674\u2013682. https:\/\/doi.org\/10.1053\/jhep.2003.50378 (2003).","journal-title":"Hepatology"},{"key":"57137_CR15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1126\/science.274.5291.1379","volume":"274","author":"DE Cressman","year":"1996","unstructured":"Cressman, D. E. et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (1979). 274, 1379\u20131383. https:\/\/doi.org\/10.1126\/science.274.5291.1379 (1996).","journal-title":"Sci. (1979)"},{"key":"57137_CR16","doi-asserted-by":"publisher","unstructured":"Yamada, Y., Kirillova, I., Peschon, J. J. & Fausto, N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. U. S. A. 94, 1441\u20131446. https:\/\/doi.org\/10.1073\/pnas.94.4.1441 (1997).","DOI":"10.1073\/pnas.94.4.1441"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57137-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57137-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57137-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:10:52Z","timestamp":1787875852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57137-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57137"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57137-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5971302\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study was performed according to the Declaration of Helsinki (as revised in 2013) and the Declaration of Istanbul. Informed consent was obtained from all patients for the use of their data for research purposes. All living donor liver transplantations included in this study were performed at Samsung Medical Center. All grafts were obtained from living donors who voluntarily donated in accordance with institutional guidelines and national regulations. No organs or tissues were procured from prisoners or other vulnerable populations.","order":2,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Samsung Medical Center (IRB No. 2020-06-165), and all participants provided informed consent.","order":3,"name":"Ethics","label":"Institutional review board","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27065"}}